Merz is defiantly seeing their aesthetic sales of Xeomin drop as Daxi continues to take cosmetic market share. Xeomin has always been the price bottom feeder and now practices can inject Daxi Lite with better outcomes and better profit than Xeomin. If you recall, Merz was sued by Allergan when Merz first launched Xoemin. Merz hired about 15 Allergan Reps ( they all resigned from Allergan...not fired) and these reps took their aesthetic customer lists on their thumb drives and used them at Merz. The final decision of the law suite required Merz to stop selling Xeomin for 12 months. Merz is trying to use the same tactic with one employee who they fired...all employees have a right to work. I am sure RVNC required this employee to sign a document which states that he will not use any Merz documents in any way and that he contacted RVNC 100%. There is no proof that this individual has caused any damage to Merz. RVNC has not sold 1 therapeutic unit. There has to be "monetary damages incurred" for a law suite to have merit, which is why the lawsuit against Merz happened about 12 months after Xeomin was launched. Allergan could then claim financial damages. This type of bulling is standard practice in this industry where the big players constantly sue the smaller players as a way to try and drive them out of business. Sad that the USDOJ allows this! This case will be dismissed and will be nothing.
On a side note, I have heard of several very large aesthetic practices ( who have used ONLY Botox and Juvederm for the the last 15 years) started with Daxi and are now switching to RHA as well. These practices will do $100,000 in Daxi sales a month and are switching 100% to RHA since RHA is a much better filler than Juvederm. The Botox/Juvederm sales team ( unusually 3 to 4 people) are offering these accounts dozens of free staff training Botox ( 100% illegal) and Juevederm to continue using Allergan Products. The reps will also offer Staff Training Juvederm as a way to offset the Botox price (again 100% Illegal) Remember, Botox is where AbbVie makes all their profits...they do not care about Juvederm, CoolSculpting, or Skin Medica. Life is all about Botox profits. The fully loaded cost to make a vial of Toxin (all companies) is about $5 to $7 dollars. Allergan knows, once an account brings in Daxi, it is only a matter of time before RHA replaces Juvederm. This is happening all over the USA! These accounts do not want the free Allergan staff training products because they now LOVE Daxi and RHA and both of these products have higher profit margins for the injector then Botox and Juvederm.
As Allergan Botox/Juvederm reps leave AbbVie, AbbVie is now merging territories and not replacing reps or managers. CoolSculpting reps and business development managers are dropping like flies. Allergan products will continue to lose market share quarter over quarter... this is what happens when your product is 20 years old and new better products enters the market. The Botox Cash Cow just keeps swinking! If you notice, Allergan keeps changing the Botox tag line...in the beginning, Botox was "The ONE and Only". now, Botox is "The One with a Proven Track Record" You can only rebrand an old product so may times and trick the aesthetic patient.......Botox should be, "The Old One who has worked well and is now retired"!!
